FIELD: medicine. SUBSTANCE: method involves intravenous administration of kalipsol, sodium thiopental and lithium oxybutyrate. Lithium oxybutyrate is used at the dose 50-60 mg/kg body mass. EFFECT: analgetic effect, stabilization of external respiration, hemodynamics, elimination of hallucination syndrome at postoperative period. 2 tbl
Authors
Dates
1996-12-10—Published
1993-03-09—Filed